Amgen Said to Agree to $26 Billion Purchase of Horizon

The transcript discusses a major $26 billion acquisition deal in the biopharma sector, marking the largest ever for an American company. Initially, both Amgen and Sanofi were contenders for the Horizon Therapeutics sale. However, Sanofi unexpectedly withdrew, leaving Amgen as the likely buyer. The market context is challenging, with other events like snow and strikes, but the focus remains on this significant deal, which could be announced soon.

What is the significance of the $26 billion deal mentioned in the video?

• It is a routine acquisition with no major impact.

• It is the smallest acquisition in the biopharma industry.

• It is a joint acquisition by multiple companies.

• It is the largest acquisition ever for the American biopharma company.

Which company unexpectedly withdrew from the acquisition process, leaving Amgen as the main contender?

• Novartis

• Sanofi

• Pfizer

• Johnson & Johnson

What was the initial expectation for the week before the acquisition news became prominent?

• Focus on a new product launch

• Attention on snow and strikes

• Discussion on a new partnership

• Analysis of a market crash

What is the current status of the acquisition agreement according to the video?

• It has been finalized and announced.

• It is still in the early negotiation stages.

• It is nearing an agreement and could be announced soon.

• It has been canceled indefinitely.

Which two companies were initially in the running for the Horizon Therapeutics sale?

• Sanofi and Novartis

• Amgen and Pfizer

• Amgen and Sanofi

• Johnson & Johnson and Amgen